RCM
NGNE icon

RA Capital Management’s Neurogene NGNE Stock Holding History

RA Capital Management’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-69,804
Closed -$19.6M – 30
2017
Q2 		$19.6M Sell
69,804
-39,398
-36% -$11.3M 2.25% 14
2017
Q1 		$36.2M Sell
109,202
-397
-0.4% -$139K 4.44% 5
2016
Q4 		$36.2M Hold
109,599
– – 5.13% 5
2016
Q3 		$29.3M Buy
109,599
+25,000
+30% +$5.04M 3.02% 11
2016
Q2 		$11.2M Hold
84,599
– – 1.55% 15
2016
Q1 		$14.9M Buy
84,599
+3,600
+4% +$700K 1.91% 15
2015
Q4 		$20.2M Buy
80,999
+4,391
+6% +$1.16M 2% 17
2015
Q3 		$21.6M Buy
+76,608
New +$17.6M 3.1% 10

Other funds holding NGNE

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

RA Capital Management's NGNE Position: Q3 2017 in Review

RA Capital Management sold out of Neurogene (NGNE) in Q3 2017, closing a stake of 69,804 shares — an estimated $19.6M sold.

RA Capital Management first reported a position in NGNE in Q3 2015 and held it in 8 quarters. The position peaked at $36.2M in Q1 2017. 43 funds tracked by Wall St. Rank hold NGNE as of Q3 2017.

  • RA Capital Management reported no remaining Neurogene position as of Q3 2017 after selling out during the quarter.
  • RA Capital Management sold 69,804 Neurogene shares in Q3 2017, an estimated $19.6M.
  • RA Capital Management first reported a position in Neurogene in Q3 2015 and held it in 8 quarters.
  • RA Capital Management's Neurogene position peaked at $36.2M in Q1 2017.
  • 43 funds tracked by Wall St. Rank held Neurogene as of Q3 2017.

Based on RA Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.